Demo Sign up Log In

Gilead Sciences (GILD)

Cost of Revenue

$1.58B

Quarterly · Period ending: Jun 30, 2026 · USD

GILD Cost of Revenue

Latest reported$1.58Bperiod endingJun 30, 2026

Latest reported$1.58Bperiod endingJun 30, 2026

GILD Quarterly Cost of Revenue ($0.00 → $1.58B)

Quarterly cost of revenue

High-resolution chart · PNG

GILD cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gilead Sciences Cost of Revenue — Quarterly (USD)
Period ending	Cost of Revenue (USD)
Jun 30, 2001	10,797,000
Mar 31, 2001	10,581,000
Dec 31, 2000	4,177,000
Sep 30, 2000	6,673,000
Jun 30, 2000	8,684,000
Mar 31, 2000	5,054,000
Dec 31, 1999	4,700,000
Sep 30, 1999	-500,000
Jun 30, 1999	4,033,000
Mar 31, 1999	4,407,000
Dec 31, 1998	-600,000
Sep 30, 1998	5,100,000
Jun 30, 1998	-600,000
Mar 31, 1998	-500,000
Dec 31, 1997	-500,000
Sep 30, 1997	-600,000
Jun 30, 1997	-400,000
Mar 31, 1997	-300,000
Dec 31, 1996	-400,000
Sep 30, 1996	-400,000
May 31, 1996	-1,700,000
Mar 31, 1996	-1,100,000
Sep 30, 1995	-1,100,000
Jun 30, 1995	-1,100,000
Mar 31, 1995	-1,100,000
Dec 31, 1994	-2,800,000
Sep 30, 1994	6,200,000
Jun 30, 1994	-900,000
Mar 31, 1994	-800,000
Dec 31, 1993	-900,000
Sep 30, 1993	-600,000
Jun 30, 1993	-500,000
Mar 31, 1993	-400,000
Dec 31, 1992	-700,000
Sep 30, 1992	-400,000
Jun 30, 1992	-400,000
Mar 31, 1992	0
Dec 31, 1991	0
Sep 30, 1991	0
Jun 30, 1991	0
Mar 31, 1991	0
Dec 31, 1990	0
Sep 30, 1990	0
Jun 30, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.